These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19527136)

  • 21. [Classification of amyloidosis].
    Misumi Y; Ando Y
    Brain Nerve; 2014 Jul; 66(7):731-7. PubMed ID: 24998818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic amyloidoses and proteomics: The state of the art.
    Lavatelli F; di Fonzo A; Palladini G; Merlini G
    EuPA Open Proteom; 2016 Jun; 11():4-10. PubMed ID: 29900105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathogenesis and biochemistry of amyloidosis.
    Cohen AS; Connors LH
    J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G; Verine J; Delpech M; Ries M
    Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twists and turns of determining amyloid type and amyloid-related organ damage: discordance and clinical skepticism in the era of proteomic typing.
    Kaul E; Pilichowska M; Vullaganti M; Madan N; Comenzo RL
    Amyloid; 2014 Mar; 21(1):62-5. PubMed ID: 24256111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AmyCo: the amyloidoses collection.
    Nastou KC; Nasi GI; Tsiolaki PL; Litou ZI; Iconomidou VA
    Amyloid; 2019 Sep; 26(3):112-117. PubMed ID: 31094220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.
    Dasari S; Theis JD; Vrana JA; Meureta OM; Quint PS; Muppa P; Zenka RM; Tschumper RC; Jelinek DF; Davila JI; Sarangi V; Kurtin PJ; Dogan A
    J Proteome Res; 2015 Apr; 14(4):1957-67. PubMed ID: 25734799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and location of a cysteinyl posttranslational modification in an amyloidogenic kappa1 light chain protein by electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
    Lim A; Wally J; Walsh MT; Skinner M; Costello CE
    Anal Biochem; 2001 Aug; 295(1):45-56. PubMed ID: 11476544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and clinical insights into protein misfolding and associated amyloidosis.
    Pande M; Srivastava R
    Eur J Med Chem; 2019 Dec; 184():111753. PubMed ID: 31622853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.
    Brambilla F; Lavatelli F; Di Silvestre D; Valentini V; Rossi R; Palladini G; Obici L; Verga L; Mauri P; Merlini G
    Blood; 2012 Feb; 119(8):1844-7. PubMed ID: 21917755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid and amyloidoses: differences, common themes, and practical considerations.
    Kisilevsky R
    Mod Pathol; 1991 Jul; 4(4):514-8. PubMed ID: 1924282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein misfolding, functional amyloid, and human disease.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2006; 75():333-66. PubMed ID: 16756495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
    Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
    Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic amyloidosis derived from EFEMP1 in a captive Tsushima leopard cat.
    Miyazaki S; Kobayashi Y; Kametani F; Kobayashi K; Iwaide S; Yanai T; Murakami T
    Vet Pathol; 2022 Jan; 59(1):152-156. PubMed ID: 34763604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of systemic amyloid deposits by mass spectrometry.
    Murphy CL; Wang S; Williams T; Weiss DT; Solomon A
    Methods Enzymol; 2006; 412():48-62. PubMed ID: 17046651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic amyloidosis: novel therapies and role of biomarkers.
    Nuvolone M; Merlini G
    Nephrol Dial Transplant; 2017 May; 32(5):770-780. PubMed ID: 27540044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesis.
    Brambilla F; Lavatelli F; Valentini V; Di Silvestre D; Obici L; Mauri P; Merlini G
    Amyloid; 2012 Jun; 19 Suppl 1():11-3. PubMed ID: 22551153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous fat tissue for diagnosis and studies of systemic amyloidosis.
    Westermark P; Davey E; Lindbom K; Enqvist S
    Acta Histochem; 2006; 108(3):209-13. PubMed ID: 16714055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.